Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Monday's Pre-Market Session

 

Gainers

  • Better Therapeutics (NASDAQ:BTTX) shares rose 42.5% to $1.3 during Monday's pre-market session. The company's market cap stands at $30.6 million.
  • LogicBio Therapeutics (NASDAQ:LOGC) shares rose 38.63% to $0.61. The market value of their outstanding shares is at $20.1 million.
  • Shattuck Labs (NASDAQ:STTK) stock increased by 10.67% to $4.25. The company's market cap stands at $180.1 million.
  • Curis (NASDAQ:CRIS) shares increased by 9.43% to $1.0. The market value of their outstanding shares is at $91.6 million.
  • Eargo (NASDAQ:EAR) shares moved upwards by 8.99% to $4.12. The market value of their outstanding shares is at $161.7 million.
  • Dermata Therapeutics (NASDAQ:DRMA) shares moved upwards by 8.73% to $1.12. The market value of their outstanding shares is at $10.3 million.

Losers

  • Stealth BioTherapeutics (NASDAQ:MITO) stock decreased by 38.7% to $0.25 during Monday's pre-market session. The market value of their outstanding shares is at $14.9 million.
  • First Wave BioPharma (NASDAQ:FWBI) stock fell 37.91% to $0.39. The market value of their outstanding shares is at $6.4 million.
  • Zosano Pharma (NASDAQ:ZSAN) shares fell 21.7% to $1.48. The market value of their outstanding shares is at $7.2 million. As per the news, the Q1 earnings report came out yesterday.
  • Belite Bio (NASDAQ:BLTE) stock decreased by 12.56% to $9.26. The market value of their outstanding shares is at $223.1 million.
  • HUTCHMED (China) (NASDAQ:HCM) stock decreased by 11.87% to $13.3. The market value of their outstanding shares is at $2.2 billion.
  • 180 Life Sciences (NASDAQ:ATNF) shares declined by 11.8% to $1.87. The market value of their outstanding shares is at $63.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.